(Q46970747)

27 December 2017

MDMA

0 references

title

MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: the contemporary human and animal research perspective (English)

1 reference

27 December 2017

author name string

Andy C Parrott

series ordinal

1

1 reference

27 December 2017

Charles A Marsden

series ordinal

2

1 reference

27 December 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

27 December 2017

Journal of Psychopharmacology

published in

1 reference

27 December 2017

volume

20

1 reference

27 December 2017

issue

2

1 reference

27 December 2017

page(s)

143-146

1 reference

27 December 2017

Self-reported ecstasy use: the impact of assessment method on dosage estimates in recreational users.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

The content of ecstasy tablets: implications for the study of their long-term effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Eating attitudes, weight concerns and beliefs about drug effects in women who use ecstasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Ecstasy: are animal data consistent between species and can they translate to humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Recreational ecstasy use and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

An investigation into the sub-acute effects of ecstasy on aggressive interpretative bias and aggressive mood - are there gender differences?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Users' perceptions of the risks and effects of taking ecstasy (MDMA): a questionnaire study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Potential human neurotoxicity of MDMA ('Ecstasy'): subjective self-reports, evidence from an Italian drug addiction centre and clinical case studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063263

21 January 2018

Identifiers

DOI

10.1177/0269881106063263

1 reference

27 December 2017

release_2cjdg5hlqrfjljfdjbb4wwlu6i

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2cjdg5hlqrfjljfdjbb4wwlu6i

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16510473

1 reference

27 December 2017